HighDose Statin May Protect Heart Surgery Patients Kidney Health
Acute kidney injury often arises after major surgery because the kidneys can be deprived of normal blood flow during the procedure. The use of contrast media or dyes can contribute to this problem. In...
View ArticleLipitor Lawsuit News Lipitor Lawsuits Conference Scheduled For This Week The...
Lipitor Lawsuits Pending In A Multidistrict Litigation In The U.S. District Court District of South Carolina Allege That Plaintiffs Who Use The CholesterolLowering Medication Develop Type 2...
View ArticleLipitor Lawsuit News Discovery Moves Ahead in Federal Multidistrict...
The Firm is currently representing clients in Lipitor lawsuits who allegedly developed newonset Type 2 diabetes due to their use of the statin medication.New York New York PRWEB January 21 2015...
View ArticleNew heart attack test shows promise for women
"Doctors could spot twice as many heart attacks in women by using a newer more sensitive blood test" BBC News reports. In women for reasons that are unclear aÂheart attack often...
View ArticleStatin use may be widening health inequalities in England
Mass prescription of statins will widen social inequalities" The Independent reports. The headline is based on a new study looking at deaths fromÂcoronary heart diseaseÂin England from the...
View ArticleStatins may benefit women as much as men
Reuters Health A large international analysis finds that statin drugs reduce heart risk factors like high cholesterol as effectively in women as they do in men.
View ArticleLipitor Lawsuits Move Forward as Judge Prepares to Select Cases for...
The Firm is representing Lipitor lawsuit plaintiffs who allegedly developed Type 2diabetes due to their use of the statin medication.New York New York PRWEB January 30 2015 Thousands of Lipitor...
View ArticleEsperion Therapeutics Announces Removal of PPAR Partial Clinical Hold for...
ANN ARBOR MIMarketwired February 02 2015 Esperion Therapeutics Inc. NASDAQ ESPR an emerging pharmaceutical company focused on developing and commercializing firstinclass oral lowdensity lipoprotein...
View ArticleSynthetic Biologics to Present at the 2015 BIO CEO & Investor Conference
ROCKVILLE Md. Feb. 3 2015 PRNewswire &160;Synthetic Biologics Inc. NYSE MKT SYN a developer of pathogenspecific therapies for serious infections and diseases with a focus on protecting the...
View ArticleFederal Lipitor Lawsuits Progress As Court Selects Cases for First Bellwether...
The Firm is representing individuals in Lipitor lawsuits that allege use of the cholesterollowering statin medication caused patients to develop newonset Type 2 diabetes.New York New York PRWEB...
View ArticleEsperion Conference Call February 2 2015 Quick Thoughts
On Monday February 2 2015 Esperion Therapeutics ESPR held a conference call after announcing that ETC1002 was cleared by the FDA to be utilized in long term treatment i.e. more than 6 months for...
View ArticleTexas Lipitor Lawsuits Allowed to Proceed in Federal Multidistrict Litigation...
The Firm is representing a number of clients in Lipitor lawsuits that allege the statin medication increases the risk that patients will develop Type 2 diabetes.New York New York PRWEB February 05 2015...
View ArticleLipitor Lawsuit News Federal Multidistrict Litigation Schedules February...
The Firm is representing Lipitor lawsuit plaintiffs who allegedly developed Type 2 diabetes due to their use of the cholesterollowering statin.New York New York PRWEB February 07 2015 The federal...
View ArticleLipitor Lawsuits Move Forward as Federal Court Issues New Order Pertaining to...
The Firm is representing a number of Lipitor lawsuit plaintiffs who allegedly developed Type 2 diabetes due to their use of the cholesterollowering statin.New York New York PRWEB February 09 2015...
View ArticleSynthetic Biologics Announces Positive Topline Results from Phase 1b Trial of...
ROCKVILLE Md. Feb. 10 2015 PRNewswire &160;Synthetic Biologics Inc. NYSE MKT SYN a developer of pathogenspecific therapies for serious infections and diseases with a focus on protecting the...
View ArticleHighintensity Statin Therapy After Hospitalization for CHD
How many Medicare beneficiaries fill prescriptions for highintensity statins after hospital discharge for a CHD event Journal of the American College of Cardiology
View ArticlePivotal announces the issuance of two patents both related to the combination...
WOODBRIDGE ON Feb. 10 2015 PRNewswire Pivotal Therapeutics Inc. OTCQXPVTTF; CSEPVO "Pivotal" or the "Company" a specialty pharmaceutical company with a focus on Omega3 therapies for cardiovascular...
View ArticleEsperion Therapeutics ESPR continues to Soar Revised Feb 13 2015
On Thursday Feburary 12 2015 ESPR closed at $67.46 with a $1.04B market cap. It started this run after the close on February 2 2015 at $44.79; Esperion management announced the removal of a partial...
View ArticleEsperion Therapeutics ESPR continues to Soar
On Thursday Feburary 12 2015 ESPR closed at $67.46 with a $1.04B market cap. It started this run after the close on February 2 2015 at $44.79; Esperion management announced the removal of a partial...
View Article